User Tag List

Page 1 of 3 123 LastLast
Results 1 to 10 of 22
  1. #1
    Super Moderator Feedback Score 2 (100%) h2s's Avatar
    Join Date
    Nov 2012
    Posts
    1,582
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)

    Archive of Steroid Profiles by Eric Potratz

    The following posts represent steroid profiles originally released by Eric Potratz for Primordial Performance.

    ©Eric Potratz, All Rights Reserved.
    Printed with Permission.

  2. #2
    Super Moderator Feedback Score 2 (100%) h2s's Avatar
    Join Date
    Nov 2012
    Posts
    1,582
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)

    Methylstenbolone

    Chemical Name(s):
    2,17a-Dimethyl-17b-hydroxy-5a-androst-1-en-3-one

    Chemical Formula:
    C21H32O2

    Molecular Weight:
    316.5

    CAS:
    NA

    Q Qatio:
    3.9

    Anabolic #:
    660

    Androgenic #:
    170

    Oral Bioavailability:
    Estimated at 50%

    AR Binding Affinity:
    NA

    SHBG Binding Affinity:
    NA

    Half Life:
    NA

    Legal Status (US):
    Not listed as a controlled substance

    Average Dose:
    5-20mg/day standalone
    1-5mg/day when stacked

    Average Cycle Length:
    2-4 weeks

    Ratings (On Scale of -5 to +5):

    Muscle Gain: +5
    Strength Gain: +5
    Fat Gain (Negative Indicates Fat loss): -1
    Water Retention: +2
    Aggression: +4
    Libido: 0
    Acne: 0
    Hair Loss: +3
    Prostate Enlargement: +3
    Liver Toxicity: +5
    Lethargy +1

    Characteristics

    Although this compound cannot convert to estrogen, it will bind strongly to SHBG, thus increasing freely circulating estrogen (and testosterone). While there is a lack of anecdotal feedback from this compound to tell the real world effect this compound may have on causing gyno, experience with related compounds tell us gyno symptoms may occur.

    Users should be very careful with methylstenbolone and start out with a very low dose. This compound will likely produce a rapid increase in intracellular water retention by inhibiting 11-beta hydroxylase and building up levels of mineralcorticoids that will encourage sodium and water retention.

    Gains upwards of 20-25lbs in 4 weeks are probably possible with this compound. However the liver toxicity issues would likely be the first reason why someone wouldn’t be able to make incredible gains from this compound. For this reason it would be extremely important to pre-condition the liver with a liver protecting supplement prior to cycling this compound, while continuing use throughout the cycle and during PCT.

    The strength increases from this compound will likely encourage weight lifting heavier than tendons and joints are prepared to lift. It is recommended to be cautious of this and to naturally build up strength levels prior to cycling this steroid.

    Using a low dose of methylstenbolone with a moderate dose of a non-methylated compound would be an acceptable way to try to limit the side-effects from this compound, although caution would still need to be taken for liver health no matter what dose is used.

    Because of the strength and weight gain this compound would offer it would likely be best used as part of a bulking cycle.

    References

    Anabolic Pharmacology
    Seth Roberts (2009)
    Last edited by h2s; 11-18-2012 at 02:53 PM.

  3. #3
    Super Moderator Feedback Score 2 (100%) h2s's Avatar
    Join Date
    Nov 2012
    Posts
    1,582
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)

    1,4,6 Androstatriene-dione (ATD)

    Chemical Name(s):
    Androsta-1,4,6-triene-3,17-dione
    1,4,6-androstatriene-3,17-dione

    Chemical Formula:
    C19H22O2

    Molecular Weight:
    282

    CAS:
    NA

    Q Qatio:
    NA

    Anabolic #:
    NA

    Androgenic #:
    NA

    Oral Bioavailability:
    Estimated at 4%

    AR Binding Affinity:
    NA

    SHBG Binding Affinity:
    NA

    Half Life:
    2 days

    Legal Status (US):
    Not listed as a controlled substance

    Average Dose:
    25-100mg/day

    Average Cycle Length:
    4-8 weeks

    Ratings (On Scale of -5 to +5):

    Muscle Gain: 0
    Strength Gain: 0
    Fat Gain (Negative Indicates Fat loss): 0
    Water Retention: 0
    Aggression: 0
    Libido: -2
    Acne: 0
    Hair Loss: 0
    Prostate Enlargement: 0
    Liver Toxicity: 0
    Lethargy 0

    Characteristics

    ATD is a steroidal aromatase inhibitor, known as a suicidal inhibitor because it permanently binds to the aromatase enzyme.

    ATD is used for its aromatase inhibiting and testosterone boosting effect. Its effectiveness at lowering estrogen appears to be stronger than 6-oxo. It converts to 1,4,6-testosterone, which would also be expected to cause falsely high readings for a testosterone analysis.

    The 1,4,6-testosterone metabolite of ATD can also bind to the androgen receptor (AR) and induce androgenic (or possibly anti-androgenic) effects similar to what is seen from 6-oxo. This would be expected since 1,4,6-testosterone has about one third the binding affinity for the AR, therefore it may interefere with the anabolic or androgenic action of hormones which bind the androgen receptor.

    ATD would also be expected to interfere with production of natural testosterone by acting upon the hypothalamus pituitary testicular axis (HPTA), therefore this compound should not be used during post cycle therapy (PCT), however it could successfully be used during a cycle to help keep estrogen in control. Anecdotal reports and animal studies have also shown ATD inhibits libido and general sexual potency.

    Common Clones:

    Arom-X by Advanced Muscle Science (AMS)
    AIFM by Anafit
    ATD MAX by Anabolic Formulations
    ATD-JET by Molecular Developments
    Reversitol by IForce

    References

    Effect of an inhibitor of aromatization, 1,4,6 androstatriene-3,17-dione (ATD) on LH release and steroid binding in hypothalamus of adult female rats.

    Exp Brain Res. 1986;64(3):407-10.
    Slama A, Gogan F, Sarrieau A, Vial M, Rostene W, Kordon C.

    Effects of ATD on male sexual behavior and androgen receptor binding: a reexamination of the aromatization hypothesis.
    ME Kaplan and MY McGinnis
    Horm Behav, Mar 1989; 23(1): 10-26.

    Anabolic Pharmacology
    Seth Roberts (2009)

  4. #4
    Super Moderator Feedback Score 2 (100%) h2s's Avatar
    Join Date
    Nov 2012
    Posts
    1,582
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)

    Cynostane

    Chemical Name(s):
    2-cyano-17a-methyl-17b-hydroxy-androstan-3-one
    2-cyano-17a-methyl-17b-hydroxy-androst-3-one (incorrect name)

    Chemical Formula:
    C21H31NO2

    Molecular Weight:
    329

    CAS:
    NA

    Q Qatio:
    NA

    Anabolic #:
    NA

    Androgenic #:
    NA

    Oral Bioavailability:
    Estimated at 40%

    AR Binding Affinity:
    NA

    SHBG Binding Affinity:
    NA

    Half Life:
    NA

    Legal Status (US):
    Not listed as a controlled substance

    Average Dose:
    40-50mg/day standalone
    20-30mg/day when stacking

    Average Cycle Length:
    4-6 weeks

    Ratings (On Scale of -5 to +5):

    Muscle Gain: +1
    Strength Gain: +2
    Fat Gain (Negative Indicates Fat loss): 0
    Water Retention: 0
    Aggression: +1
    Libido: +1
    Acne: 0
    Hair Loss: +1
    Prostate Enlargement: +1
    Liver Toxicity: +2
    Lethargy +1

    Characteristics


    2-cyano-dromostolone is a 17aa molecule relatively new to the scene with very few reviews as of yet.

    It has a cyano group attached to the 2 position. The chemical structure is the same as methyldrostanolone (Superdrol), except it has a CN group on the 2 position instead of a methyl group. It is a C-17aa steroid and it will be liver toxic. Although, due to the lack of the 4-ene on ring A and lack of 2-methylation, liver toxicity may be reduced relative to a di-methylated steroid such as Superdrol.

    So far, feedback is very limited for this compound. However results would be expected to be fairly lean as this compound cannot convert to estrogen. Based on the chemical structure the anabolic potency would appear to be fairly potent with moderate androgenic potency.

    At the time of this writing there was only one manufacturer to bring this product to the market and there seems to have been a nomenclature mistake on the labeling for this steroid. The chemical name contains the term “androst”, assuming that there is some sort of ene group on ring A. But there does not seem to be such mention of an ene group on ring A. Therefore, the term androst should be androstan. But if this is the case, the 2-cyano group needs to be stated as alpha or beta. This makes a big difference, since usually C2-alpha groups are significantly more effective than beta.

    There are studies about other 2-cyano steroids such as 2-cyano-DHT and 2-cyano-progesterone. In separate studies, one done on dogs, it was seen that both of these 2-cyano steroids caused inhibition of 3b-HSD enzyme. This inhibition would cause severe adrenal suppression. This is a very unsafe inhibition. Whether it occurs in this cyano steroid is unknown, but users need to be aware of this possibility.

    Common Clones:

    Cynostane by Anabolic Innovation

    References

    Anabolic Pharmacology
    Seth Roberts (2009)

  5. #5
    Super Moderator Feedback Score 2 (100%) h2s's Avatar
    Join Date
    Nov 2012
    Posts
    1,582
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)

    Androstenetrione (6-OXO)

    Chemical Name(s):
    4-androsten-3,6,17-trione
    3,6,17-androstenetrione
    androst-4-ene-3,6,17-trione
    6-ketoandrostenedione

    Chemical Formula:
    C19H24O3

    Molecular Weight:
    300

    CAS:
    NA

    [B]Q Qatio: [/B
    ]NA

    Anabolic #:
    NA

    [B]Androgenic #: [/B
    ]NA

    Oral Bioavailability:
    Estimated at 4%

    AR Binding Affinity:
    NA

    SHBG Binding Affinity:
    NA

    Half Life:
    3-6 hours

    Legal Status (US):
    Not listed as a controlled substance

    Average Dose:
    300-600mg/day

    Average Cycle Length:
    4-8 weeks

    Ratings (On Scale of -5 to +5):

    Muscle Gain: 0
    Strength Gain: 0
    Fat Gain (Negative Indicates Fat loss): 0
    Water Retention: 0
    Aggression: 0
    Libido: -1
    Acne: +1
    Hair Loss: 0
    Prostate Enlargement: +1
    Liver Toxicity: 0
    Lethargy 0

    Characteristics

    6-OXO is a steroidal aromatase inhibitor, known as a suicidal inhibitor because it permanently binds to the aromatase enzyme.

    It is used for its anti-estrogen and testosterone boosting effects.

    There is debate about whether or not 6-oxo actually lowers estrogen or increases testosterone. Several human studies have shown an increase in estrone levels following 6-oxo supplementation. However, one of the primary metabolites of 6-oxo is 6-oxoestrone which may have given a false positive for elevated estrone levels. The human study also concluded that 6-oxo raised testosterone levels, however it is possible that 6-oxotestosterone (which is another metabolite of 6-oxo) gave a false positive for the testosterone level as well.

    Another interesting element to these articles is that despite the supposed increase in testosterone (enough to cause significant improvements in body composition if given via injection) no improvements where found for fat free mass (FFM) or strength. Therefore, 6-oxo is either a weak AI that doesn’t really inhibit estrogen at the recommended dose and simply converts to metabolites which give false readings, or it actually does increase testosterone, while the 6-oxo metabolites antagonize the androgen receptor enough to block any anabolic effect from testosterone.

    Either way, no ergonomic or real world benefit could be found after 6-oxo supplementation.

    Its also worth mentioning that 6-oxo should never be used post cycle, as its steroidial effects would likely interfere with recovery of natural testosterone production.

    References

    Immunological interference of the synthetic aromatase inhibitor 1,4,6-androstatriene-3,17-dione (ATD) and its metabolite(s) in the radioimmunoassay for testosterone.

    MD Donaldson and MG Forest
    Steroids, Dec 1980; 36(6): 717-21

    Testosterone dose-response relationships in healthy young men
    Shalender Bhasin, et al.
    Am J Physiol Endocrinol Metab, Dec 2001; 281: E1172 – E1181.

  6. #6
    Super Moderator Feedback Score 2 (100%) h2s's Avatar
    Join Date
    Nov 2012
    Posts
    1,582
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)

    1-Androsterone

    Chemical Name(s):
    1-androsten-3b-ol-17-one
    1-Dehydroepiandrosterone

    Chemical Formula:
    C19H28O2

    Molecular Weight:
    NA

    CAS:
    NA

    Q Qatio:
    NA

    Anabolic #:
    NA

    Androgenic #:
    NA

    Oral Bioavailability:
    Estimated at 8%

    AR Binding Affinity:
    NA

    SHBG Binding Affinity:
    NA

    Half Life:
    NA

    Legal Status (US):
    Not listed as a controlled substance

    Average Dose:
    200-300mg/day Transdermally
    400-600mg/day standalone (oral)
    200-400mg/day when stacking (oral)

    Average Cycle Length:
    4-6 weeks

    Ratings (On Scale of -5 to +5):

    Muscle Gain: +2
    Strength Gain: +2
    Fat Gain (Negative Indicates Fat loss): 0
    Water Retention: 0
    Aggression: 0
    Libido: -2
    Acne: +1
    Hair Loss: +1
    Prostate Enlargement: 0
    Liver Toxicity: 0
    Lethargy +3

    Characteristics

    1- Androsteronetm (1-DHEA) is a non-methylated (non 17aa) pro-steroid that must convert to 1-androstenediol (1-AD), 1-androstenedione (original 1-AD) and/or 1-testosterone to be active. The double bond in the 1st position seems to slightly enhance its ability to resist excretion by the liver.

    1-Androsterone occurs naturally in the body, and is a naturally occurring metabolite of DHEA. (2) The 17b-HSD enzyme converts 1-Androsterone to 1-Androstenediol, and the 3b-HSD converts it to 1-Androstenedione. Both of these 1-AD metabolites can then be converted to 1-Testosterone. Although the 1-AD metabolites are known to have some anabolic and androgenic effects on their own, 1-Testosterone is probably where most of the effects come from with this steroid.

    There is no conversion to estrogen so users will not experience bloat with this compound, nor will it have a dramatic effect on blood pressure. However one unique side effect that users have reported with this compound is a feeling of lethargy. (It appears that stacking 1-Androsterone with a nuero-active hormone such as DHEA can help reverse this effect)

    1-Androsterone (and primarily its metabolites) have relatively potent androgenic effects, therefore gyno is almost never an issue. However, because of the androgenic potency, this compound could pose a mild hair loss risk for those prone to MPB. Because this steroid is non-17aa there should be less concern about it negatively affecting the HDL/LDL ratio.

    Results from this compound generally take a couple weeks to be realized. Moderate gains of lean muscle mass and strength can be expected, but users should not expect rapid increases in size or weight with this compound since extra-cellular and intra-cellular water retention are very minimal. This makes the gains from this steroid fairly easy to maintain post cycle.

    1-Androsterone will stack well with almost any compound. For more dramatic gains in size and strength it is recommended to stack this compound with an aromatizing steroid or possibly one of the progestational compounds listed elsewhere.

    Common Clones:

    1-T by Primordial Performance
    1-Androsterone by Advanced Muscle Science (AMS)

    References

    1. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.

    A Friedel, et al.
    Toxicol Lett, Aug 2006; 165(2): 149-55.

    2. “Metabolism of 1-Dehydroandrostanes in Man”
    Galletti and Gardi, et al.
    J Steroid Biochem, 3 (1972), 933-936

  7. #7
    Super Moderator Feedback Score 2 (100%) h2s's Avatar
    Join Date
    Nov 2012
    Posts
    1,582
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)

    Exemestane (Aromasin)

    Chemical Name(s):
    6-methyleneandrosta-1,4-dien-3,17-dione

    Chemical Formula:
    C20H24O2

    Molecular Weight:
    296

    CAS:
    NA

    Q Qatio:
    NA

    Anabolic #:
    NA

    Androgenic #:
    NA

    Oral Bioavailability:
    Estimated at 15%

    AR Binding Affinity:
    NA

    SHBG Binding Affinity:
    NA

    Half Life:
    27 hours

    Legal Status (US):
    Prescription only

    Average Dose:
    10-25mg/day

    Average Cycle Length:
    4-8 weeks

    Ratings (On Scale of -5 to +5):

    Muscle Gain: 0
    Strength Gain: 0
    Fat Gain (Negative Indicates Fat loss): -1
    Water Retention: -1
    Aggression: 0
    Libido: -1
    Acne: 1
    Hair Loss: 0
    Prostate Enlargement: 0
    Liver Toxicity: 0
    Lethargy 0

    Characteristics

    Exemestane is a steroidal aromatase inhibitor, known as a suicidal inhibitor because it permanently binds to the aromatase enzyme.

    Exemestane is one of the most potent and expensive steroidal aromatase inhibitors currently available on the market. It is available by prescription only. The estrogen inhibition rate for exemestane varies from 85% of estradiol to 95% for estrone.

    Exemestane is looked highly upon due to the fact it can be just as effective as Letrozole or Arimidex without causing such a rapid rebound of estrogen, which is a typical problem of non-suicidal aromatase inhibitors.

    Exemstane is rarely dosed beyond 25mg/day as this appears to be a high enough dose to suppress estrogen by a significant amount. It can reach maximum estrogen suppression in as little as 7 days. Since it increases testosterone levels, some users may experience androgenic effects.

    References

    Anabolic Pharmacology
    Seth Roberts (2009)

  8. #8
    Super Moderator Feedback Score 2 (100%) h2s's Avatar
    Join Date
    Nov 2012
    Posts
    1,582
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)

    1,4-AD (Boldione)

    Chemical Name(s):

    1,4-androstadiene-3b,17b-dione
    androst-1,4-diene-3b,17b-dione
    1,4-Androstenedione

    Chemical Formula:
    C19H24O2

    Molecular Weight:
    284.4

    CAS:
    NA

    Q Qatio:
    NA

    Anabolic #:
    NA

    Androgenic #:
    NA

    Oral Bioavailability:
    Estimated at 8%

    AR Binding Affinity:
    NA

    SHBG Binding Affinity:
    Low

    Half Life:
    NA

    Legal Status (US):
    Listed as a controlled substance

    Average Dose:
    800-1500mg/day standalone
    400-1000mg/day when stacking

    Average Cycle Length:
    6 weeks

    Ratings (On Scale of -5 to +5):

    Muscle Gain: +2
    Strength Gain: +2
    Fat Gain (Negative Indicates Fat loss): 0
    Water Retention: +1
    Aggression: 0
    Libido: 0
    Acne: +1
    Hair Loss: 0
    Prostate Enlargement: +1
    Liver Toxicity: 0
    Lethargy 0

    Characteristics

    Boldione is NOT a 17-alpha alkylated steroid, therefore high doses must be taken to accommodate for its rapid excretion from the liver.

    Boldione itself likely does not have any significant anabolic or androgenic value. However after interaction with the 17b-HSD enzyme, boldione is converted to the illegal anabolic steroid boldenone. Boldione can also be converted to 1-androstenedione (1-AD) and/or 1-testosterone after interaction with the 5a-reductase enzyme. These metabolites are where this pro-hormone gets most of its effects.

    Since boldione is a dione, conversions to the more powerful steroid metabolites are expected to be near 15-20%, which is another reason why such high doses are needed to see results.

    This pro-hormone (and its metabolites) do not convert very readily to estrogen, so an aromatase inhibitor would likely not be needed during a cycle.

    Results can be expected to kick in slowly after several weeks. Moderate gains in size and strength should be expected. This compound also has a tendency to increase appetite, which makes it a good choice for bulking.

    Side effects are minimal with boldione, but can become more noticeable with doses above 1000mg/day. Side-effects may include increases blood pressure and oily skin. Overall, results and side-effects would be similar to that of boldenone, including lean mass gains with low bloating. Because this steroid is non-17aa there should be less concern about it negatively affecting the HDL/LDL ratio.

    Although this compound can be used as a standalone, it is recommended to stack this compound with an already active steroid, as the high doses of boldione will likely saturate most of the steroid conversion enzymes.

    Common Clones:

    BOLD by IForce
    EQ-Plex by Competitive Edge Labs (CEL)
    BOLD 200 by IForce
    EQ-Jet by Molecular Development
    P-Bold by Proven Products

    References

    “Criteria to distinguish between natural situations and illegal use of boldenone, boldenone esters and boldione in cattle: 1. Metabolite profiles of boldenone, boldenone esters and boldione in cattle urine.”

    Bruno Le Bizec, Frédérique Courant, Isabelle Gaudin, Emanuelle Bichon, Blandine Destrez,
    Robert Schilt, Rosa Draisci, Fabrice Monteau and François André
    Steroids; Volume 71, Issues 13-14, December 2006, Pages 1078-1087

    "An in vitro study on metabolism of 17β-boldenone and boldione using cattle liver and kidney subcellular fractions”
    R. Merlanti, G. Gallina, F. Capolongo, L. Contiero, G. Biancotto, M. Dacasto and C. Montesissa

    “Pathology of the testicle and sex accessory glands following the administration of boldenone and boldione as growth promoters in veal calves”
    Cannizzo, F.T.(Universita degli Studi di Torino (Italy)); Zancanaro, G.; Spada, F.; Mulasso, C.; Biolatti
    Nov 2007 Veterinary science and hygiene

  9. #9
    Super Moderator Feedback Score 2 (100%) h2s's Avatar
    Join Date
    Nov 2012
    Posts
    1,582
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)

    Methoxygonadiene

    Chemical Name(s):
    13-ethyl-3-methoxy-gona-2,5(10)-diene-17-one
    13b-ethyl-3-methoxy-2,5 (10)-gona-diene-17-one

    Chemical Formula:
    C20H28O2

    Molecular Weight:
    300

    CAS:
    NA

    Q Qatio:
    NA

    Anabolic #:
    NA

    Androgenic #:
    NA

    Oral Bioavailability:
    Estimated at 20%

    AR Binding Affinity:
    NA

    SHBG Binding Affinity:
    NA

    Half Life:
    NA

    Legal Status (US):
    Not listed as a controlled substance

    Average Dose:

    50-75mg/day standalone
    25-50mg/day when stacked

    Average Cycle Length:
    4 weeks

    Ratings (On Scale of -5 to +5):

    Muscle Gain: +3
    Strength Gain: +2
    Fat Gain (Negative Indicates Fat loss): +2
    Water Retention: +3
    Aggression: +1
    Libido: +2
    Acne: +1
    Hair Loss: 0
    Prostate Enlargement: 0
    Liver Toxicity: +1
    Lethargy +1

    Characteristics

    Methoxygonadiene is not a 17aa steroid so liver toxicity is not as harsh as with 17aa steorids, however the ethyl group on C-18 may make it slightly more toxic than a non-ethylated steroid (while increasing its oral bio-availability). The progestational activity of methoxygonadiene (once it is converted to its active metabolites) is considered to be slightly stronger than nandrolone.

    In the stomach acid, the C-3 methoxy group is rapidly cleaved off and the double bond on the A ring at C-2 is lost. At this point, a 3-oxo is formed and a metabolite known as 13b-ethyl-nor-androstenedione is created, which is chemically similar to norbolethone, and probably where this compound gets most of its effects.

    13b-ethyl-nor-androstenedione is about equal to testosterone in anabolic potency, yet less androgenic. This would make this compound fairly light on the hairline with minimal chance of acne or other androgenic side-effects.

    With low androgenic activity, this compound may negatively affect the libido and erectile function. The lack of androgenic potency and progestational effects make this compound likely to cause gyno symptoms. Users could stack this compound with testosterone or one of its non-aromatizing metabolites to preserve DHT levels and possibly prevent these side-effects.

    Users experience rapid weight gain from this compound partly due to subcutaneous water retention from the progestational activity. Therefore the overall gains from this compound may lead to a bloated appearance. Because of the progestational effects, users should avoid stacking this compound with other gyno aggravating compounds. Methoxygonadiene can aromatize to estrogen in small amounts, however not to any significant degree, therefore an aromatase inhibitor would provide little protection against this compounds side-effects.

    Common Clones:

    Revolt by KiloSports
    M-LMG by Competitive Edge Labs (CEL)
    X-MASS by Generic Labs
    Deiselbolan by Mrsupps

    References

    Anabolic Pharmacology
    Seth Roberts (2009)

  10. #10
    Super Moderator Feedback Score 2 (100%) h2s's Avatar
    Join Date
    Nov 2012
    Posts
    1,582
    Mentioned
    0 Post(s)
    Tagged
    0 Thread(s)

    Stanozolol THP

    Chemical Name(s):
    [3,2-c]pyrazole-5alpha-etioallocholane-17b-tetrahydropyranol

    Chemical Formula:
    C25H38N2O2

    Molecular Weight: 3
    99

    CAS:
    NA

    Q Qatio:
    NA

    Anabolic #:
    NA

    Androgenic #:
    NA

    Oral Bioavailability:
    Estimated at 15%

    AR Binding Affinity:
    NA

    SHBG Binding Affinity:
    Medium

    Half Life:
    4-6 hours

    Legal Status (US):
    Not listed as a controlled substance

    Average Dose:
    200-300mg/day standalone
    100-200mg/day when stacked

    Average Cycle Length:
    4-6 weeks

    Ratings (On Scale of -5 to +5):

    Muscle Gain: +2
    Strength Gain: +2
    Fat Gain (Negative Indicates Fat loss): -1
    Water Retention: -1
    Aggression: 0
    Libido: 0
    Acne: 1
    Hair Loss: +2
    Prostate Enlargement: +1
    Liver Toxicity: +1
    Lethargy +1

    Characteristics

    Stanozolol THP is the same compound as the illegal anabolic steroid stanozolol (Winstrol) except it is not 17aa methylated, and instead has a THP ether attached on the 17b position.

    The conversion rate for this compound is very low, expected to be less than 15%. Knowing this, users are better off taking doses in the 150-250mg range. The downfall to this is the high cost.

    Stanozolol THP does not aromatize and also has very minimal bloat. It has a moderately potent androgenic activity, giving it a fairly low risk for gyno or negative effects on the libido. However its androgenic effects may pose a problem for users prone to androgenic related hair loss.

    Once the Stanozolol THP reaches the stomach, most of the THP-ether is probably removed by the stomach acid to form stanozolol (the non-methylated version). Therefore, topical delivery of this compound is probably not worthwhile.

    Overall this compound produces mild gains, but the side-effects are very mild too. Noticeable gains in lean muscle mass and strength are not likely going to be achieved unless doses of at least 200mg/day are used. Stanozolol THP is going to produce very little water retention, therefore it should produce a lean and vascular appearance. Big increases in weight are not likely to happen with this steroid either, so increased blood pressure and painful back pumps should not be a problem.

    This compound would work well for cutting cycles and would stack well almost any other steroid depending on the goals.


    Common Clones:

    WinZstrol by Juggarnaught Nutrition
    Prostanzonol by Juggarnaught Nutrition
    Prostanozol by Generic Labs
    Prostanozol by Anabolic Xtreme
    P-Stanz by Competitive Edge Labs (CEL)
    Orastan-E by Gaspari Nutrition

    References

    “Metabolism and excretion of anabolic steroids in doping control—New steroids and new insights”
    Peter Van Eenoo and Frans T. Delbeke

    The Journal of Steroid Biochemistry and Molecular Biology; Volume 101, Issues 4-5, November
    2006, Pages 161-178

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •